Brought to you by 
Cardiome gets clinical-stage CV drug from Eli Lilly
03 May 2007
Executive Summary
Eli Lilly has granted cardiovascular drug company Cardiome Pharma exclusive worldwide rights to develop and market LY458202 in all indications.
Deal Industry
- Pharmaceuticals
-
Biotechnology
- Large Molecule
Deal Status
- Final
Deal Type
-
Alliance
- R&D and Marketing (Licensing)
- Reverse Licensing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com